4 Evaluating Plasma GFAP for the Detection of Alzheimer’s Disease Dementia

Objective:Blood-based biomarkers represent a scalable and accessible approach for the detection and monitoring of Alzheimer’s disease (AD). Plasma phosphorylated tau (p-tau) and neurofilament light (NfL) are validated biomarkers for the detection of tau and neurodegenerative brain changes in AD, res...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the International Neuropsychological Society 2023-11, Vol.29 (s1), p.408-409
Hauptverfasser:	Ally, Madeline, Zetterberg, Henrik, Blennow, Kaj, Ashton, Nicholas J., Karikari, Thomas K., Aparicio, Hugo, Sugarman, Michael A., Frank, Brandon, Tripodis, Yorghos, McKee, Ann C., Stein, Thor D., Martin, Brett, Palmisano, Joseph N., Steinberg, Eric G., Simkina, Irene, Farrer, Lindsay, Jun, Gyungah, Turk, Katherine W., Budson, Andrew E., O’Connor, Maureen K., Au, Rhoda, Qiu, Wei Qiao, Goldstein, Lee E., Killiany, Ronald, Kowall, Neil W., Stern, Robert A., Mez, Jesse, Alosco, Michael L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Accuracy Alzheimer's disease Apolipoprotein E4 Biomarkers Cognition & reasoning Cognitive ability Dementia Dementia (Alzheimer’s Disease) Dementia disorders Executive function Glial fibrillary acidic protein Neurodegenerative diseases Neuropsychology Plasma Poster Session 04: Aging \| MCI Regression analysis Tau protein
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!